Akinori Nakayama

Akinori Nakayama

Auto-generated profile, based on publicly available information

Akinori Nakayama

Department of Urology Dokkyo Medical University Saitama Medical Center Saitama Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2020 in American Journal of Men's Health
Verified
Journal Article
Open access
PDF file
ANAkinori Nakayama
Akinori Nakayama
HIHisamitsu Ide
Hisamitsu Ide
AOAkiyoshi Osaka
Akiyoshi Osaka
YIYasuyuki Inoue
Yasuyuki Inoue
YSYukihito Shimomura
Yukihito Shimomura
HOHiroshi Okada
Hiroshi Okada
As testicular torsion is a medical emergency, it requires quick diagnosis and treatment. Color Doppler ultrasound (CDUS) is useful for the diagnosis of testicular torsion. An accurate diagnosis can be difficult when CDUS indicates the preservation of blood flow in the testis. We examined the accuracy of testicular torsion diagnosis in patients with acute scrotum made by doctors on duty using CDUS. The subjects included 26 patients who visited our department between January 2016 and June 2018 presenting with acute scrotal pain. Patients were placed into one of three groups based on testicular blood flow evaluated by CDUS. The first group had no testicular blood flow, the second had diminished blood flow, and the last group had normal or increased blood flow. Patients were also diagnosed through scrotal exploration. Finally, patients were further divided into two groups identified by CDUS frequency utilized during diagnosis (12 MHz groups and ≤8 MHz groups), and the diagnostic accuracy of the two groups was compared. Characterizing torsion by either the absence of or diminished, testicular blood flow in the CDUS evaluation, the sensitivity and specificity of the CDUS performed by doctors on duty accounted for 69.2% and 53.8%, respectively. No improvement in diagnostic accuracy was evident despite the usage of a 12-MHz ultrasonic transducer. In this study, the sensitivity of CDUS performed by doctors on duty was about 70%, suggesting that scrotal exploration should be performed promptly even if testicular blood flow is observed and testicular torsion is suspected from medical history and body findings.

18 September 2025 in International Journal of Urology
Verified
Journal Article
Closed access
HTHiroki Tsujioka
Hiroki Tsujioka
KIKeita Izumi
Keita Izumi
ANAkinori Nakayama
Akinori Nakayama
KSKiyoshi Setoguchi
Kiyoshi Setoguchi
KSKazutaka Saito
Kazutaka Saito

8 June 2026 in International Journal of Urology
Verified
Journal Article
Closed access
PDF file
SYShugo Yajima
Shugo Yajima
SYSoichiro Yoshida
Soichiro Yoshida
SFShohei Fukuda
Shohei Fukuda
WCWei Chen
Wei Chen
HSHiroyuki Sato
Hiroyuki Sato
YFYasuhisa Fujii
Yasuhisa Fujii

2 February 2026 in International Journal of Urology
Verified
Journal Article
Open access
TSTakeshi Sasaki
Takeshi Sasaki
AIAtsushi Igarashi
Atsushi Igarashi
SEShin Ebara
Shin Ebara
TTTomoyuki Tatenuma
Tomoyuki Tatenuma
YIYoshinori Ikehata
Yoshinori Ikehata
TAKAHIRO INOUETAKAHIRO INOUE
TAKAHIRO INOUE
Objectives: To explore clinicopathological risk factors associated with the development of castration‐resistant prostate cancer (CRPC) in patients who underwent robot‐assisted radical prostatectomy (RARP). Methods: This study was conducted in nine Japanese institutions between 2012 and 2021. Patients with clinically metastatic PCa, those who received neoadjuvant or adjuvant therapy, were excluded. Consequently, 2825 patients with PCa were analyzed. Persistent prostate‐specific antigen (PSA) was determined as a level ≥ 0.2 ng/mL at 1 month postoperatively and consistently in subsequent measurements. Results: Median follow‐up was 42.0 months. Under follow‐up, 493 (17.4%) and 25 (0.8%) patients progressed to biochemical recurrence and CRPC, respectively. One hundred and ninety‐six patients received salvage radiation therapy, and 229 patients received salvage androgen deprivation therapy. Among the 25 patients with CRPC, the median time to CRPC was 31.8 months. Univariate analysis revealed that preoperative PSA level, biopsy grade group (GG) 5, percentage of positive cancer cores, GG5 in RARP specimens, pT3b, pN1, positive surgical margins, lymphovascular invasion (LVI), and persistent PSA levels were associated with CRPC development. Multivariate analysis revealed that biopsy GG5 (adjusted hazard ratio [aHR] 12.74, p < 0.001), LVI (aHR 3.90, p = 0.011), and persistent PSA levels (aHR 8.66, p < 0.001) were independently associated with CRPC development. Furthermore, using these three factors made it possible to stratify CRPC‐free survival among patients with PCa who received RARP and confirmed external validation. Conclusions: The combination of biopsy GG5, LVI, and persistent PSA levels may stratify the risk of developing CRPC in patients with PCa undergoing RARP.

7 October 2026 in International Journal of Urology
Verified
Journal Article
Closed access
SSShinpei Saito
Shinpei Saito
TSTomokazu Sazuka
Tomokazu Sazuka
SWSatoshi Washino
Satoshi Washino
GKGo Kaneko
Go Kaneko
SNShoichi Nagamoto
Shoichi Nagamoto
Shinichi SakamotoShinichi Sakamoto
Shinichi Sakamoto